| Acute urinary retention | 61 |
| Adrenal | 80 |
| Adrenal cyst | 110 |
| Adrenalectomy | 80 |
| Antiandrogens | 5 |
| Antibiotherapy | 52 |
| Antibiotic prophylaxis | 130 |
| Antibiotic resistance | 130 |
| Benign prostatic obstruction | 52 |
| Bladder | 68 |
| Bladder cancer | 24, 134 |
| Bladder explosion | 140 |
| Bladder injury | 140 |
| Bladder tumor | 113 |
| Bone metastasis | 98 |
| Bowel recovery | 93 |
| Case report | 58 |
| Child | 20 |
| Clinical significance | 40 |
| Cognitive biopsy | 35 |
| Combined biopsy | 40 |
| COVID-19 | 134 |
| COVID-19 pandemic | 119 |
| Creatinine | 14 |
| Cystitis | 142 |
| DAP score | 45 |
| Delay | 134 |
| Diagnosis | 87 |
| Early diagonosis | 71 |
| Elderly patients | 73 |
| Epidemiology | 1 |
| Extraperitoneal approach | 93 |
| Fluoroquinolones | 130 |
| Fusion biopsy | 35 |
| Ga-68 PSMA PET/MRI | 32 |
| Germ cell tumour | 105 |
| Giant | 68, 110 |
| Glomerular filtration rate | 14 |
| Guidelines | 87 |
| Hormonotherapy | 5 |
| Ileus | 93 |
| Image-guided biopsy | 130 |
| Incidentaloma | 80 |
| International society of urological pathology score | 10 |
| Intrapelvic mass | 61 |
| Ischemia | 14 |
| Laparoscopic partial nephrectomy | 45 |
| Laparoscopy | 14, 110 |
| Leiomyoma | 144 |
| Lipid profiles | 5 |
| Macrophages | 142 |
| Malignant somatic transformation | 105 |
| Management | 73 |
| Metabolic syndrome | 124 |
| Metastasis | 32 |
| MRI US fusion | 40 |
| Multiparametric prostate MRI | 35 |
| Nephrometry score | 45 |
| Obstruction | 68 |
| Orchiectomy | 65 |
| PADUA score | 45 |
| Paratesticular liposarcoma | 58 |
| Partial cystectomy | 24 |
| Partial nephrectomy | 14 |
| PI-RADS | 35 |
| Pregnant | 110 |
| Prognostic factors | 98 |
| Progression | 134 |
| Prostate | 1, 130 |
| Prostate biopsy | 1, 35, 124 |
| Prostate cancer | 1, 5, 10, 32, 35, 40, 73, 87, 98, 124 |
| Prostate needle biopsy | 52 |
| Prostate-specific antigen | 124 |
| Prostatitis | 52 |
| Quality of life | 24 |
| Radical cystectomy | 93 |
| Radical prostatectomy | 10 |
| RCC | 119 |
| Recurrence | 134 |
| RENAL score | 45 |
| Sarcoma | 65 |
| Screening | 87 |
| Scrotal masses | 58 |
| Scrotum | 144 |
| Seminoma | 71 |
| Sertoli cell | 28 |
| Squamous cell carcinoma | 113 |
| Synovial sarcoma | 61 |
| Targeted biopsy | 40 |
| Teratoma | 105 |
| Testicular cancer | 71, 105 |
| Testicular neoplasms | 144 |
| Testicular tumor | 20, 65, 71 |
| Testis | 28 |
| Testis sparing surgery | 20 |
| Treatment | 28, 119 |
| Tumor | 28 |
| Tumor size | 71 |
| TURP | 140 |
| Unusual | 32 |
| Urinary bladder neoplasms | 142 |
| Urinary retention | 68 |
| Urologic oncology | 65 |
| Urothelial carcinoma | 113 |